Vaidya Sane Ayurved Laboratories (MADHAVBAUG) Share Price Falls 10.63% Today
- October 21, 2026
- Posted by: Kunal Singla
- Category: News
Vaidya Sane Ayurved Laboratories Share Price fell 10.63% and was trading at Rs 140 as of 21 October 2026 at 2:23:06 PM IST, with market capitalisation at Rs 164.69 crore. The move took the stock below the previous close of Rs 156.65 after a trade that opened at the same level, touched a high of Rs 156.65 and a low of Rs 140. For readers tracking Vaidya Sane Ayurved Laboratories Share Price, the key point is simple: the stock moved lower inside the same range and the price event is confirmed, but no company-specific catalyst is established. In Univest data, the decline is notable because it comes in a Micro Cap healthcare name and therefore stands out in today’s Stock News and Share Price Today discussion.
According to latest Univest figures, Vaidya Sane Ayurved Laboratories Share Price is the main event, while the relevant context is the company’s valuation, profitability ratios and its place in the Hospital & Healthcare Services industry. Investors watching Vaidya Sane Ayurved Laboratories Share Price News typically focus next on whether the current price remains aligned with those fundamentals and with the healthcare benchmark set by larger listed peers.
Vaidya Sane Ayurved Laboratories (MADHAVBAUG) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 140 |
| Previous Close | Rs 156.65 |
| Today's Move | -Rs 16.65 (-10.63%) |
| Open | Rs 156.65 |
| High | Rs 156.65 |
| Low | Rs 140 |
| Market Capitalisation | Rs 164.69 crore |
| Market Cap Category | Micro Cap |
Vaidya Sane Ayurved Laboratories Share Price today reflects a Rs 16.65 decline from the previous close, equal to 10.63%, with the stock trading at Rs 140 versus Rs 156.65 earlier in the day. The day open, day high and previous close were all Rs 156.65, while the day low was Rs 140, so the entire move was contained within that opening-to-low range. Market capitalisation stood at Rs 164.69 crore, placing the company in the Micro Cap category. For Vaidya Sane Ayurved Laboratories Share Price, the day’s action is a clean downward move without any extra price levels being formed beyond the low. From a stock analysis angle, the fall is best understood as a price event on the screen, not as a statement on business quality. That is why Univest separates the share price move from the fundamental analysis that follows.
Vaidya Sane Ayurved Laboratories (MADHAVBAUG) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 164.69 crore |
| P/E Ratio | 18.33x |
| P/B Ratio | 2.63x |
| ROE | 13.66% |
| ROCE | 16.7% |
| EPS | Rs 8.55 |
| Book Value Per Share | Rs 59.48 |
| Dividend Yield | 0% |
Vaidya Sane Ayurved Laboratories (MADHAVBAUG) fundamental metrics show P/E 18.33x, P/B 2.63x, ROE 13.66%, ROCE 16.7%. Read together, these ratios describe the company’s position rather than a recommendation.
Vaidya Sane Ayurved Laboratories has a market capitalisation of Rs 164.69 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 18.33x, P/B at 2.63x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 13.66% and ROCE of 16.7%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 8.55, book value per share of Rs 59.48, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 42.55x, median ROE of 13.07%, median ROCE of 15.83%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Hospital & Healthcare Services |
| Benchmark Scope | same industry |
| Company P/E Ratio | 18.33x |
| Benchmark Median P/E | 42.55x |
| Benchmark Average P/E | 92.69x |
| Benchmark P/E Range | 6.24x to 1,525.06x |
| Company P/B Ratio | 2.63x |
| Benchmark Median P/B | 3.63x |
| Benchmark Average P/B | 3.86x |
| Company ROE | 13.66% |
| Benchmark Median ROE | 13.07% |
| Benchmark Average ROE | 10.69% |
| Company ROCE | 16.7% |
| Benchmark Median ROCE | 15.83% |
| Benchmark Average ROCE | 1.93% |
| Company Market Capitalisation | Rs 164.69 crore |
| Benchmark Median Market Cap | Rs 541.51 crore |
| Benchmark Average Market Cap | Rs 9,858.2 crore |
Vaidya Sane Ayurved Laboratories (MADHAVBAUG) operates in the Healthcare sector, within the Hospital & Healthcare Services industry.
Vaidya Sane Ayurved Laboratories (MADHAVBAUG) has a P/E ratio of 18.33x, which is below the benchmark median of 42.55x, a difference of -56.92%. The P/E comparison frames valuation; it is not a signal to buy or sell.
Vaidya Sane Ayurved Laboratories (MADHAVBAUG) has a ROE of 13.66%, which is above the benchmark median of 13.07%, a difference of +4.51%. Vaidya Sane Ayurved Laboratories (MADHAVBAUG) has a ROCE of 16.7%, which is above the benchmark median of 15.83%, a difference of +5.5%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Apollo Hospitals Enterprise | APOLLOHOSP | 1,10,757.32 | 53.01 | 11.44 | 23.54 | 21.73 |
| MANIPAL HEALTH ENTERPRI L | MANIPALHOS | 82,855.61 | 92.85 | 4.99 | 12.95 | 13.93 |
| Max Healthcare Institute | MAXHEALTH | 80,716.62 | 55.4 | 7.39 | 14.53 | 14.97 |
| Aster DM Healthcare | ASTERDM | 58,157.99 | 182.5 | 13.75 | 13.07 | 16.22 |
| Fortis Healthcare | FORTIS | 55,553.6 | 53.01 | 5.47 | 11.32 | 14.07 |
Vaidya Sane Ayurved Laboratories (MADHAVBAUG) has a P/E ratio of 18.33x compared with the displayed peer median of 55.4x. Peer multiples give relative context only, not a buy or sell view. Its ROE of 13.66% compares with a peer median of 13.07% across the companies shown in the table. ROCE stood at 16.7% versus the displayed peer median of 14.97%, providing a capital-efficiency comparison. Vaidya Sane Ayurved Laboratories (MADHAVBAUG) has a market capitalisation of Rs 164.69 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Vaidya Sane Ayurved Laboratories
- Vaidya Sane Ayurved Laboratories Share Price fell 10.63% today and moved from Rs 156.65 to Rs 140.
- The stock is a Micro Cap with market capitalisation of Rs 164.69 crore, which keeps price moves closely watched in market news.
- P/E of 18.33 and P/B of 2.63 are below the same-industry medians, giving the share price a distinct valuation profile.
- ROE of 13.66% and ROCE of 16.7% are above the benchmark medians, which adds context to the fundamental analysis.
- Vaidya Sane Ayurved Laboratories Share Price sits well below larger healthcare peers in market capitalisation, making comparison important.
About Vaidya Sane Ayurved Laboratories
Vaidya Sane Ayurved Laboratories operates in the Healthcare sector and the Hospital & Healthcare Services industry. The company is tracked in Univest data as a Micro Cap stock with a market capitalisation of Rs 164.69 crore. Its core financial profile includes earnings per share of Rs 8.55, book value of Rs 59.48 and a dividend yield of 0. The business context matters because Vaidya Sane Ayurved Laboratories Share Price is often assessed against both its own size and the broader healthcare set, where larger chains command much higher market capitalisation and different valuation bands. In stock news terms, the company is therefore a smaller healthcare name with measurable earnings and return ratios.
Track Vaidya Sane Ayurved Laboratories Share Price on Univest
Use Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
You can track Vaidya Sane Ayurved Laboratories Share Price on Univest for live price movement, fundamental ratios, 52-week levels and market insights in one place. The platform also helps you follow Vaidya Sane Ayurved Laboratories Stock News, Share Price Today and valuation context without switching between multiple pages. Univest keeps the company’s stock performance, market cap view and key financial ratios connected for easier review.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why did Vaidya Sane Ayurved Laboratories Share Price fall today?
Ans. Vaidya Sane Ayurved Laboratories Share Price fell 10.63% to Rs 140 today. Univest data confirms the move itself, though no company-specific trigger has been identified. The move also came from a previous close of Rs 156.65.
What is the current Vaidya Sane Ayurved Laboratories Share Price?
Ans. Vaidya Sane Ayurved Laboratories Share Price was Rs 140 as of 21 October 2026 at 2:23:06 PM IST. The stock traded below its previous close of Rs 156.65 after opening at Rs 156.65 earlier in the day.
How much did Vaidya Sane Ayurved Laboratories Share Price decline today?
Ans. Vaidya Sane Ayurved Laboratories Share Price declined by Rs 16.65, or 10.63%. The move took the stock from Rs 156.65 to Rs 140 and kept the day’s low at Rs 140.
What is the market capitalisation of Vaidya Sane Ayurved Laboratories?
Ans. Vaidya Sane Ayurved Laboratories has a market capitalisation of Rs 164.69 crore. Univest data places it in the Micro Cap category, which is important context when comparing the stock with larger healthcare peers.
How does Vaidya Sane Ayurved Laboratories Share Price compare with sector valuation?
Ans. Vaidya Sane Ayurved Laboratories Share Price carries a P/E of 18.33 and a P/B of 2.63. Both are below the healthcare industry medians of 42.55 and 3.63, respectively, in the same-industry benchmark.
What do the return ratios show for Vaidya Sane Ayurved Laboratories?
Ans. Vaidya Sane Ayurved Laboratories reports ROE of 13.66% and ROCE of 16.7%. Both sit above the industry medians of 13.07% and 15.83%, which gives additional context to Vaidya Sane Ayurved Laboratories Share Price.
What is the EPS and book value for Vaidya Sane Ayurved Laboratories?
Ans. EPS is Rs 8.55 and book value is Rs 59.48 per share. Those figures help frame Vaidya Sane Ayurved Laboratories Share Price because they show earnings per share and accounting net worth per share.
Does Vaidya Sane Ayurved Laboratories pay a dividend?
Ans. Dividend yield is 0% for Vaidya Sane Ayurved Laboratories. That means the current profile does not include a dividend return, so investors studying Vaidya Sane Ayurved Laboratories Share Price are primarily looking at earnings and valuation.
How does Vaidya Sane Ayurved Laboratories compare with healthcare peers?
Ans. Vaidya Sane Ayurved Laboratories Share Price is supported by a much smaller market capitalisation than Apollo Hospitals, Manipal Health, Max Healthcare, Aster DM and Fortis. Its P/E is also lower than those peers in the comparison set.
